Basit öğe kaydını göster

dc.contributor.authorBousquet, J. and Ansotegui, I.J. and Anto, J.M. and Arnavielhe, S. and Bachert, C. and Basagaña, X. and Bédard, A. and Bedbrook, A. and Bonini, M. and Bosnic-Anticevich, S. and Braido, F. and Cardona, V. and Czarlewski, W. and Cruz, A.A. and Demoly, P. and De Vries, G. and Dramburg, S. and Mathieu-Dupas, E. and Erhola, M. and Fokkens, W.J. and Fonseca, J.A. and Haahtela, T. and Hellings, P.W. and Illario, M. and Ivancevich, J.C. and Jormanainen, V. and Klimek, L. and Kuna, P. and Kvedariene, V. and Laune, D. and Larenas-Linnemann, D. and Lourenço, O. and Onorato, G.L. and Matricardi, P.M. and Melén, E. and Mullol, J. and Papadopoulos, N.G. and Pfaar, O. and Pham-Thi, N. and Sheikh, A. and Tan, R. and To, T. and Tomazic, P.V. and Toppila-Salmi, S. and Tripodi, S. and Wallace, D. and Valiulis, A. and van Eerd, M. and Ventura, M.T. and Yorgancioglu, A. and Zuberbier, T.
dc.date.accessioned2020-07-02T05:43:48Z
dc.date.available2020-07-02T05:43:48Z
dc.date.issued2019
dc.identifier.citationcited By 5
dc.identifier.urihttps://www.scopus.com/inward/record.uri?eid=2-s2.0-85073068318&doi=10.1016%2fj.jaip.2019.07.044&partnerID=40&md5=583826ed45b3a040e607b3f69250700a
dc.identifier.urihttp://hdl.handle.net/20.500.12481/11383
dc.description.abstractSmart devices and Internet-based applications (apps) are largely used in allergic rhinitis and may help to address some unmet needs. However, these new tools need to first of all be tested for privacy rules, acceptability, usability, and cost-effectiveness. Second, they should be evaluated in the frame of the digital transformation of health, their impact on health care delivery, and health outcomes. This review (1) summarizes some existing mobile health apps for allergic rhinitis and reviews those in which testing has been published, (2) discusses apps that include risk factors of allergic rhinitis, (3) examines the impact of mobile health apps in phenotype discovery, (4) provides real-world evidence for care pathways, and finally (5) discusses mobile health tools enabling the digital transformation of health and care, empowering citizens, and building a healthier society. © 2019 American Academy of Allergy, Asthma & Immunology
dc.language.isoEnglish
dc.publisherAmerican Academy of Allergy, Asthma and Immunology
dc.titleMobile Technology in Allergic Rhinitis: Evolution in Management or Revolution in Health and Care?
dc.typeArticle
dc.contributor.departmentUniversity Hospital, Montpellier, France; MACVIA-France, Fondation partenariale FMC VIA-LR, Montpellier, France; VIMA, INSERM U 1168, VIMA: Ageing and chronic diseases Epidemiological and public health approaches, Villejuif, Université Versailles St-Quentin-en-Yvelines, Montigny le Bretonneux, France; Euforea, Brussels, Belgium; Charité, Universitätsmedizin Berlin, Humboldt-Universität zu Berlin, Berlin, Germany; Department of Dermatology and Allergy, Berlin Institute of Health, Comprehensive Allergy Center, Berlin, Germany; Department of Allergy and Immunology, Hospital Quirónsalud Bizkaia, Erandio, Spain; ISGlobAL, Centre for Research in Environmental Epidemiology (CREAL), Barcelona, Spain; Hospital del Mar Research Institute, Barcelona, Spain; CIBER Epidemiología y Salud Pública (CIBERESP), Barcelona, Spain; Universitat Pompeu Fabra (UPF), Barcelona, Spain; KYomed INNOV, Montpellier, France; Upper Airways Research Laboratory, ENT Department, Ghent University Hospital, Ghent, Belgium; UOC Pneumologia, Istituto di Medicina Interna, F Policlinico Gemelli IRCCS, Università Cattolica del Sacro Cuore, Rome, Italy; National Heart and Lung Institute, Royal Brompton Hospital & Imperial College London, London, United Kingdom; Woolcock Institute of Medical Research, University of Sydney, Glebe, NSW, Australia; Woolcock Emphysema Centre and Sydney Local Health District, Glebe, NSW, Australia; Department of Internal Medicine (DiMI), University of Genoa, Genova, Italy; IRCCS Ospedale Policlinico San Martino, Genova, Italy; Allergy Section, Department of Internal Medicine, Hospital Vall d'Hebron & ARADyAL Research Network, Barcelona, Spain; Medical Consulting Czarlewski, Levallois, France; ProAR—Nucleo de Excelencia em Asma, Federal University of Bahia, Salvador, Brazil; WHO GARD Planning Group, Salvador, Brazil; Department of Pulmonology, Division of Allergy, Hôpital Arnaud de Villeneuve, University Hospital of Montpellier, Montpellier, France; Equipe EPAR—IPLESP, Sorbonne Université, Paris, France; Peercode BV, Geldermalsen, Netherlands; Department of Pediatric Pulmonology, Immunology and Intensive Care Medicine, Charité—University Medicine Berlin, Berlin, Germany; National Institute for Health and Welfare, Helsinki, Finland; Department of Otorhinolaryngology, Amsterdam University Medical Centres, AMC, Amsterdam, Netherlands; CINTESIS, Center for Research in Health Technology and Information Systems, Faculdade de Medicina da Universidade do Porto, Porto, Portugal; Medida, Lda, Porto, Portugal; Skin and Allergy Hospital, Helsinki University Hospital, and University of Helsinki, Helsinki, Finland; Department of Otorhinolaryngology, University Hospitals Leuven, Leuven, Belgium; Academic Medical Center, University of Amsterdam, Amsterdam, Netherlands; Division for Health Innovation, Campania Region and Federico II University Hospital Naples (R&D and DISMET), Naples, Italy; Servicio de Alergia e Immunologia, Clinica Santa Isabel, Buenos Aires, Argentina; Center for Rhinology and Allergology, Wiesbaden, Germany; Division of Internal Medicine, Asthma and Allergy, Barlicki University Hospital, Medical University of Lodz, Lodz, Poland; Institute of Biomedical Sciences, Department of Pathology, Faculty of Medicine, Vilnius University, Vilnius, Lithuania; Institute of Clinical Medicine, Clinic of Chest Diseases and Allergology, Faculty of Medicine, Vilnius University, Vilnius, Lithuania; Center of Excellence in Asthma and Allergy, Médica Sur Clinical Foundation and Hospital, México City, Mexico; Faculty of Health Sciences and CICS—UBI, Health Sciences Research Centre, University of Beira Interior, Covilhã, Portugal; AG Molecular Allergology and Immunomodulation, Department of Pediatric Pneumology and Immunology, Charité Medical University, Berlin, Germany; E. Sachs' Children and Youth Hospital, Södersjukhuset, Stockholm, Sweden; Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden; Rhinology Unit & Smell Clinic, ENT Department, Hospital Clínic, Barcelona, Spain; Clinical & Experimental Respiratory Immunoallergy, IDIBAPS, CIBERES, University of Barcelona, Barcelona, Spain; Division of Infection, Immunity & Respiratory Medicine, Royal Manchester Children's Hospital, University of Manchester, Manchester, United Kingdom; Allergy Department, 2nd Pediatric Clinic, Athens General Children's Hospital “P&A Kyriakou”, University of Athens, Athens, Greece; Department of Otorhinolaryngology, Head and Neck Surgery, Section of Rhinology and Allergy, University Hospital Marburg, Phillipps-Universität Marburg, Marburg, Germany; Allergy Department, Pasteur Institute, Paris, France; The Usher Institute of Population Health Sciences and Informatics, The University of Edinburgh, Edinburgh, United Kingdom; Sidkkids Hospital and Institute of Health Policy, Management and Evaluation, Toronto, Ontario, Canada; Department of General ORL, H&NS, Medical University of Graz, Graz, Austria; Allergy Unit, Policlinico Casilino, Rome, Italy; Nova Southeastern University, Fort Lauderdale, Fla, United States; Institute of Clinical Medicine, Clinic of Children's Diseases, Vilnius University, Vilnius, Lithuania; Institute of Health Sciences, Department of Public Health, Vilnius University, Vilnius, Lithuania; European Academy of Paediatrics (EAP/UEMS-SP), Brussels, Belgium; University of Bari Medical School, Unit of Geriatric Immunoallergology, Bari, Italy; Department of Pulmonary Diseases, Faculty of Medicine, Celal Bayar University, Manisa, Turkey; Charité—Universitätsmedizin Berlin, Berlin, Germany; Corporate member of Freie Universität Berlin, Humboldt-Uniersität zu Berlin, and Berlin Institute of Health, Comprehensive Allergy-Centre, Department of Dermatology and Allergy, Berlin, Germany; Member of GA<sup>2</sup>LEN, Berlin, Germany
dc.identifier.DOI-ID10.1016/j.jaip.2019.07.044
dc.identifier.volume7
dc.identifier.pages2511-2523


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

  • Scopus [2994]
    Scopus İndeksli Yayınlar Koleksiyonu

Basit öğe kaydını göster